Photo taken from Amol Akhade/Twitter
Nov 29, 2023, 19:32
Amol Akhade: India made cervical cancer vaccine is non inferior to original made by MSD in phase 2/3 RCT
Amol Akhade, Consultant Medical Oncologist/Hematologist at Suyog Cancer Clinics, posted on Twitter:
“So India made cervical cancer vaccine ( Cervavac ) is non inferior to original made by MSD ( Gardasil ) in phase 2/3 RCT. It is less than Half as costly as Original. This will make cervical cancer vaccine more accessible and affordable, not only to LMICs but to HICs also.”
Source: Amol Akhade/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19